Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
97.81%
-
Total 13F principal
-
$398,604,472
-
Principal change
-
+$761,519
-
Total reported market value
-
$388,810,196
-
Number of holders
-
46
-
Value change
-
+$2,236,901
-
Number of buys
-
18
-
Number of sells
-
21
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q2 2020
As of 30 Jun 2020,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
46 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$398,604,472
in principal (par value) of the bond.
The largest 10 bondholders included
Allianz Asset Management GmbH, Western Asset Management Company, LLC, LMR Partners LLP, Radcliffe Capital Management, L.P., WESTWOOD HOLDINGS GROUP INC., JUPITER ASSET MANAGEMENT LTD, WELLS FARGO & COMPANY/MN, SYMPHONY ASSET MANAGEMENT LLC, ONTARIO TEACHERS PENSION PLAN BOARD, and OAKTREE CAPITAL MANAGEMENT LP.
This page lists
46
institutional bondholders reporting positions
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.